-transparent.png){kind=logo}
We studied the effect of anti-insulin antibodies (AIA) on glycemia control in patients with insulin-dependent diabetes (IDD) by following the AIA titer changes with time. Although expected to remain constant, AIA levels were found to either increase or decrease in most patients. These AIA titer changes correlated significantly with changes in glycohemoglobin but not with changes in insulin dose. The results suggest that AIA may have a deleterious effect on glycemia control in IDD.
Related Publications
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
December 1986,
Immunological investigations,
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
May 1987,
Immunological investigations,
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
May 1977,
Annals of internal medicine,
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
April 1973,
La Nouvelle presse medicale,
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
January 1990,
Revista medica de Chile,
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
June 2022,
International journal of molecular sciences,
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
October 1975,
The Quarterly journal of medicine,
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
February 1976,
British medical journal,
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
January 1989,
Diabetes research and clinical practice,
A Livneh, and
H Avraham, and
T Bistritzer, and
L Weisglass, and
R Theodor, and
J Sack
February 1982,
Diabetologia,
